Baylor College of Medicine (BCM) is a new applicant for continuation of the Womens and Infants Transmission Study (WITS) in the form of WITS Il. At the time of the application for WITS I in 1987, there was neither a suitable patient population in Houston nor an organized center for conduct of natural history studies of HIV-infected women and their infants. Since that time, however, a large maternal-infant population infected with HIV has been identified and a highly organized and efficient National Institutes of Health (NIH)-Pediatric-Obstetrical HIV Research Center has been formed by BCM and the University of Texas Medical School in Houston (UT). BCM-UT now seeks to perform WITS II research as part of its coordinated recruitment of HIV-infected mother-infant pairs into natural history, diagnostic, and therapeutic clinical trials programs. By using the combined strengths of other NIH grants and contracts plus the facilities of the general Clinical Research Center (GCRC) at the BCM- affiliated Texas Children's Hospital, it will be possible to enroll 50 mother-infant pairs per year into WITS II with a greater economy of effort and financial resources than otherwise would be possible. Specifically the BCM-UT WITS Il unit will recruit 50 HIV-infected mother-infant pairs into a 4-year natural history study of the effects of HIV on pregnant women and their infants. Additionally, WITS II will attempt to answer certain specific research questions, such as whether natural factors influence the incidence of vertical HIV transmission. This research question is based on the hypothesis that maternal factors such as depressed immunity (e.g. low CD4+ cell counts), contribute to an enhanced HIV mother-to-infant transmission rate. Moreover, WITS II will add to its original goals by determining the natural history of HIV infection in pregnant women and their infants who have been exposed to antiretroviral agents, prophylactic agents, and immune-based therapies. By recruiting annually at least 50 HIV-infected mother-infant pairs from a largely minority inner city disadvantaged population, BCM-UT will make a substantial contribution to the national WITS II program and enable it to meet its goals of understanding the natural history of HIV disease in the United States.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI034840-03
Application #
2070044
Study Section
Special Emphasis Panel (SRC (90))
Project Start
1993-07-01
Project End
1997-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Welles, Seth L; Bauer, Greta R; LaRussa, Philip S et al. (2007) Time trends for HIV-1 antiretroviral resistance among antiretroviral-experienced and naive pregnant women in New York City during 1991 to early 2001. J Acquir Immune Defic Syndr 44:329-35
Bauer, Greta R; Colgrove, Robert C; Larussa, Philip S et al. (2006) Antiretroviral resistance in viral isolates from HIV-1-transmitting mothers and their infants. AIDS 20:1707-12
Colgrove, Robert C; Millet, Amy; Bauer, Greta R et al. (2005) Gag-p6 Tsg101 binding site duplications in maternal-infant HIV infection. AIDS Res Hum Retroviruses 21:191-9
LaMonte, Ashley C; Paul, Mary E; Read, Jennifer S et al. (2004) Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study. J Infect Dis 189:847-51
Ioannidis, John P A; Tatsioni, Athina; Abrams, Elaine J et al. (2004) Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis. AIDS 18:99-108
Llorente, Antolin; Brouwers, Pim; Charurat, Manhattan et al. (2003) Early neurodevelopmental markers predictive of mortality in infants infected with HIV-1. Dev Med Child Neurol 45:76-84
Tuomala, Ruth E; Shapiro, David E; Mofenson, Lynne M et al. (2002) Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 346:1863-70
LaRussa, Philip; Magder, Laurence S; Pitt, Jane et al. (2002) Association of HIV-1 viral phenotype in the MT-2 assay with perinatal HIV transmission. J Acquir Immune Defic Syndr 30:88-94
Read, J S; Tuomala, R; Kpamegan, E et al. (2001) Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study. J Acquir Immune Defic Syndr 26:236-45
Macmillan, C; Magder, L S; Brouwers, P et al. (2001) Head growth and neurodevelopment of infants born to HIV-1-infected drug-using women. Neurology 57:1402-11

Showing the most recent 10 out of 21 publications